Academic and industry researchers and clinicians will present the most recent research on both type 1 and type 2 diabetes, based on which prevention and advanced cures are close to implementation.

This exciting symposium will be of great interest to anyone wanting to understand the molecular bases of one of the most prevalent diseases of humans; those curious to perceive how research can be translated into therapies; those, associated with pharmaceutical companies ready to transfer science into applications and those who want to teach beyond textbook information.

Sessions cover diabetes type 1 immunology; beta cell biology; genetics of type 1 and 2 diabetes; insulin signaling in type 2 diabetes; fat cells and diabetes; diabetes complications and cures.

For your chance to join our program submit your abstract before November 7, 2016.

Yours sincerely,

Symposium Directors:
Sylvia Daunert, University of Miami Miller School of Medicine, USA (Chair)
Angelo Azzi, Tufts University, USA
Joseph Kissil, The Scripps Research Institute, USA
Stephen Nimer, University of Miami Miller School of Medicine, USA
Claes Wahlestedt, University of Miami Miller School of Medicine, USA
William J. Whelan, University of Miami Miller School of Medicine, USA

For further information on the symposium and to sign up for email updates visit:
www.miamiwintersymposium.com